Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
(Q58971166)
scientific article published on 01 December 2007
scientific article published on 01 December 2007
Language:
Current Data About
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
other details
description | scientific article published on 01 December 2007 |
External Links
(P356) |
10.1359/JBMR.070809
|
(P698) |
17708711
|